JPML To Weigh Consolidation Of Darvocet Cases
The U.S. Judicial Panel on Multidistrict Litigation issued a show cause order for plaintiffs in 10 states seeking centralization of cases alleging Xanodyne Pharmaceuticals Inc., Eli Lilly & Co. and others concealed the health risks about the drugs' active ingredient, propoxyphene.
Plaintiffs in Florida, Pennsylvania, Mississippi, Maryland, Ohio, Oklahoma, Illinois, Louisiana, New...
To view the full article, register now.